Precision Biosciences DTIL
NASDAQ DTIL
$6.33 +0.07 (+1.12%)
At close: Oct 1, 2026 · 4:00 PM EDT

Precision Biosciences (DTIL) Return on Equity [ROE] (2018 - 2026)

Updated

Precision Biosciences' Return on Equity [ROE] was -48.49% in fiscal Q2 2026 (quarter ended Jun 30, 2026), up 139.20 percentage points from -187.68% a year earlier but down 7.58 percentage points from the prior quarter.

Analysis

Precision Biosciences (DTIL) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025 (ended Dec 31, 2025), Return on Equity [ROE] at Precision Biosciences came in at -61.52%, down 80.57 percentage points from FY2024.

  • Return on Equity [ROE] shows a five-year change of +57.78 percentage points (FY2020 to FY2025).
  • In earlier fiscal years, Return on Equity [ROE] was 19.05% in FY2024 (+173.71 pp), -154.66% in FY2023 (-7.39 pp), -147.28% in FY2022 (-89.31 pp) and -57.97% in FY2021 (+61.33 pp).
  • Quarterly Return on Equity [ROE] has moved between -329.87% (fiscal Q3 2025) and 30.32% (fiscal Q2 2024) over five years.
  • Compared with a year earlier, Return on Equity [ROE] was higher in five of the last eight quarters, with an average year-over-year change of +6.55 percentage points.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q2 2024 (a gain of 271.19 percentage points); the worst was fiscal Q3 2025 (a drop of 342.22 percentage points).
  • Per Business Quant data, DTIL's Return on Equity [ROE] in the three fiscal quarters before Q2 2026 was -40.90% (Q1 2026), -85.61% (Q4 2025) and -329.87% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Precision Biosciences 165.47 Mn -183.71 Mn - -48.49%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -48.49%
Mar 31, 2026 -40.90%
Dec 31, 2025 -85.61%
Sep 30, 2025 -329.87%
Jun 30, 2025 -187.68%
Mar 31, 2025 -41.59%
Dec 31, 2024 11.82%
Sep 30, 2024 12.36%
Jun 30, 2024 30.32%
Mar 31, 2024 -98.71%
Dec 31, 2023 -255.90%
Sep 30, 2023 -233.01%
Jun 30, 2023 -240.87%
Mar 31, 2023 -212.77%
Dec 31, 2022 -150.79%
Sep 30, 2022 -118.89%
Jun 30, 2022 -114.68%
Mar 31, 2022 -59.46%
Dec 31, 2021 -40.81%
Sep 30, 2021 -31.72%
API Access

Precision Biosciences Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DTIL&period=max&api_key=YOUR_API_KEY